155 related articles for article (PubMed ID: 8380956)
1. Detection of thrombomodulin in human lung cancer cells.
Tamura A; Matsubara O; Hirokawa K; Aoki N
Am J Pathol; 1993 Jan; 142(1):79-85. PubMed ID: 8380956
[TBL] [Abstract][Full Text] [Related]
2. NSP-encoded reticulons are neuroendocrine markers of a novel category in human lung cancer diagnosis.
van de Velde HJ; Senden NH; Roskams TA; Broers JL; Ramaekers FC; Roebroek AJ; Van de Ven WJ
Cancer Res; 1994 Sep; 54(17):4769-76. PubMed ID: 8062278
[TBL] [Abstract][Full Text] [Related]
3. Differential expression and pathological significance of autocrine motility factor/glucose-6-phosphate isomerase expression in human lung carcinomas.
Dobashi Y; Watanabe H; Sato Y; Hirashima S; Yanagawa T; Matsubara H; Ooi A
J Pathol; 2006 Dec; 210(4):431-40. PubMed ID: 17029220
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value and clinicopathological correlation of thrombomodulin in squamous cell carcinoma of the human lung.
Hamatake M; Ishida T; Mitsudomi T; Akazawa K; Sugimachi K
Clin Cancer Res; 1996 Apr; 2(4):763-6. PubMed ID: 9816228
[TBL] [Abstract][Full Text] [Related]
5. Nuclear A-type lamins are differentially expressed in human lung cancer subtypes.
Broers JL; Raymond Y; Rot MK; Kuijpers H; Wagenaar SS; Ramaekers FC
Am J Pathol; 1993 Jul; 143(1):211-20. PubMed ID: 8391215
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical analysis of tissue localization of cytokeratin 19 in lung cancer.
Chyczewski L; Nikliński J; Chyczewska E; Laudański J; Furman M
Rocz Akad Med Bialymst; 1997; 42 Suppl 1():162-72. PubMed ID: 9337534
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical detection of cluster 1 small cell lung cancer antigen and chromogranin A in lung carcinomas.
Noguchi M; Hirohashi S; Shimosato Y
Jpn J Clin Oncol; 1992 Feb; 22(1):6-9. PubMed ID: 1315401
[TBL] [Abstract][Full Text] [Related]
8. Neutral endopeptidase: variable expression in human lung, inactivation in lung cancer, and modulation of peptide-induced calcium flux.
Cohen AJ; Bunn PA; Franklin W; Magill-Solc C; Hartmann C; Helfrich B; Gilman L; Folkvord J; Helm K; Miller YE
Cancer Res; 1996 Feb; 56(4):831-9. PubMed ID: 8631021
[TBL] [Abstract][Full Text] [Related]
9. Bcl-2 protein expression in lung cancer and close correlation with neuroendocrine differentiation.
Jiang SX; Kameya T; Sato Y; Yanase N; Yoshimura H; Kodama T
Am J Pathol; 1996 Mar; 148(3):837-46. PubMed ID: 8774138
[TBL] [Abstract][Full Text] [Related]
10. High-level expression of CD109 is frequently detected in lung squamous cell carcinomas.
Sato T; Murakumo Y; Hagiwara S; Jijiwa M; Suzuki C; Yatabe Y; Takahashi M
Pathol Int; 2007 Nov; 57(11):719-24. PubMed ID: 17922683
[TBL] [Abstract][Full Text] [Related]
11. Integrin (alpha 6/beta 4) expression in human lung cancer as monitored by specific monoclonal antibodies.
Mariani Costantini R; Falcioni R; Battista P; Zupi G; Kennel SJ; Colasante A; Venturo I; Curio CG; Sacchi A
Cancer Res; 1990 Sep; 50(18):6107-12. PubMed ID: 2393872
[TBL] [Abstract][Full Text] [Related]
12. Synchronous primary lung cancer presenting with small cell carcinoma and non-small cell carcinoma: diagnosis and treatment.
Hiraki A; Ueoka H; Yoshino T; Chikamori K; Onishi K; Kiura K; Bessho A; Mimoto J; Date H; Ando A; Shimizu N; Harada M
Oncol Rep; 1999; 6(1):75-80. PubMed ID: 9864405
[TBL] [Abstract][Full Text] [Related]
13. An immunohistochemical study of lung carcinomas using a monoclonal antibody which specifically reacts to basal cells.
Maeda K; Sueishi K
Mod Pathol; 1990 Jan; 3(1):43-8. PubMed ID: 2155419
[TBL] [Abstract][Full Text] [Related]
14. Expression of nucleolar protein p120 in human lung cancer: difference in histological types as a marker for proliferation.
Uchiyama B; Saijo Y; Kumano N; Abe T; Fujimura S; Ohkuda K; Handa M; Satoh K; Nukiwa T
Clin Cancer Res; 1997 Oct; 3(10):1873-7. PubMed ID: 9815576
[TBL] [Abstract][Full Text] [Related]
15. First establishment of a human monoclonal antibody directed to sulfated glycosphingolipids SM4s-Gal and SM4g, from a patient with lung cancer.
Miyake M; Taki T; Kannagi R; Hitomi S
Cancer Res; 1992 Apr; 52(8):2292-7. PubMed ID: 1313742
[TBL] [Abstract][Full Text] [Related]
16. [The immunohistochemical study of p53 protein in primary lung cancer].
Jiang Y; He AG; Dai XC
Zhonghua Jie He He Hu Xi Za Zhi; 1994 Feb; 17(1):45-6, 63. PubMed ID: 8082221
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibodies in lung cancer pathology.
Broers JL; Klein Rot M; de Leij L; Wagenaar SS; Carney DN; Vooijs GP; Ramaekers FC
Eur J Respir Dis Suppl; 1987; 149():11-8. PubMed ID: 2438150
[TBL] [Abstract][Full Text] [Related]
18. Identification of the retinoic acid-inducible Gprc5a as a new lung tumor suppressor gene.
Tao Q; Fujimoto J; Men T; Ye X; Deng J; Lacroix L; Clifford JL; Mao L; Van Pelt CS; Lee JJ; Lotan D; Lotan R
J Natl Cancer Inst; 2007 Nov; 99(22):1668-82. PubMed ID: 18000218
[TBL] [Abstract][Full Text] [Related]
19. Cholecystokinin-B/gastrin receptor: a novel molecular probe for human small cell lung cancer.
Matsumori Y; Katakami N; Ito M; Taniguchi T; Iwata N; Takaishi T; Chihara K; Matsui T
Cancer Res; 1995 Jan; 55(2):276-9. PubMed ID: 7812957
[TBL] [Abstract][Full Text] [Related]
20. Prognostic role of proliferating cell nuclear antigen in lung cancer: an immunohistochemical analysis.
Caputi M; Esposito V; Groger AM; Pacilio C; Murabito M; Dekan G; Baldi F; Wolner E; Giordano A
In Vivo; 1998; 12(1):85-8. PubMed ID: 9575430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
